|
|
|
|
Tenofovir Disoproxil Fumarate (TDF) in Asian Patients With High Baseline HBV-DNA Viral Load (HBV DNA ≥9 log10 copies/mL)
|
|
|
Reported by Jules Levin
Asian Pacific Association for the Study of the Liver (APASL) Liver Week, June 6-10, 2013, Singapore
Scott Fung1, Stuart C. Gordon2, Zachary Krastev3, Andrzej Horban4, Jorg Petersen5, Jan Sperl6, Leland J. Yee7, Phillip Dinh7, Eduardo B. Martins7, John F. Flaherty7, Kathryn M. Kitrinos7, Vinod K. Rustgi8, Maria Buti9, Patrick Marcellin10
1University of Toronto, Toronto, Ontario, Canada; 2Henry Ford Health System, Detroit, MI, USA; 3University Hospital, St Ivan Rilsky, Sofia, Bulgaria; 4Warsaw Medical University, Warsaw, Poland; 5Liver Unit Asklepios Klinik St Georg, Hamburg, Germany; 6Institute for Clinical and Experimental Medicine, Prague, Czech Republic; 7Gilead Sciences, Inc., Foster City, CA, USA; 8Metropolitan Liver Diseases, Fairfax, VA, USA; 9Hospital General Universitari Vall d«Hebron, Barcelona, Catalonia, Spain; 10Hopital Beaujon, University of Paris, Clichy, France
|
|
|
|
|
|
|